Annual Accounts Payable
$4.65 M
-$16.43 M-77.95%
December 31, 2023
Summary
- As of February 8, 2025, INO annual accounts payable is $4.65 million, with the most recent change of -$16.43 million (-77.95%) on December 31, 2023.
- During the last 3 years, INO annual accounts payable has risen by +$3.18 million (+216.53%).
- INO annual accounts payable is now -83.38% below its all-time high of $27.97 million, reached on December 31, 2021.
Performance
INO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.39 M
-$1.02 M-15.97%
September 30, 2024
Summary
- As of February 8, 2025, INO quarterly accounts payable is $5.39 million, with the most recent change of -$1.02 million (-15.97%) on September 30, 2024.
- Over the past year, INO quarterly accounts payable has increased by +$737.20 thousand (+15.86%).
- INO quarterly accounts payable is now -86.39% below its all-time high of $39.57 million, reached on June 30, 2022.
Performance
INO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
INO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.0% | +15.9% |
| 3 y3 years | +216.5% | -86.4% |
| 5 y5 years | -57.8% | -86.4% |
INO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.4% | at low | -86.4% | +38.0% |
| 5 y | 5-year | -83.4% | +216.5% | -86.4% | +266.7% |
| alltime | all time | -83.4% | +1132.0% | -86.4% | >+9999.0% |
Inovio Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.39 M(-16.0%) |
| Jun 2024 | - | $6.41 M(-22.8%) |
| Mar 2024 | - | $8.30 M(+78.5%) |
| Dec 2023 | $4.65 M(-78.0%) | $4.65 M(+19.1%) |
| Sep 2023 | - | $3.90 M(-62.3%) |
| Jun 2023 | - | $10.36 M(-17.9%) |
| Mar 2023 | - | $12.61 M(-40.2%) |
| Dec 2022 | $21.08 M(-24.6%) | $21.08 M(+47.8%) |
| Sep 2022 | - | $14.27 M(-63.9%) |
| Jun 2022 | - | $39.57 M(+0.1%) |
| Mar 2022 | - | $39.52 M(+41.3%) |
| Dec 2021 | $27.97 M(+1804.9%) | $27.97 M(-4.0%) |
| Sep 2021 | - | $29.15 M(-8.5%) |
| Jun 2021 | - | $31.87 M(+19.2%) |
| Mar 2021 | - | $26.74 M(+1721.1%) |
| Dec 2020 | $1.47 M(-80.8%) | $1.47 M(-94.0%) |
| Sep 2020 | - | $24.33 M(+37.2%) |
| Jun 2020 | - | $17.73 M(+57.1%) |
| Mar 2020 | - | $11.28 M(+47.5%) |
| Dec 2019 | $7.65 M(-30.6%) | $7.65 M(-25.4%) |
| Sep 2019 | - | $10.25 M(-27.0%) |
| Jun 2019 | - | $14.04 M(-17.2%) |
| Mar 2019 | - | $16.96 M(+53.9%) |
| Dec 2018 | $11.02 M(+29.8%) | $11.02 M(-38.8%) |
| Sep 2018 | - | $18.02 M(+36.4%) |
| Jun 2018 | - | $13.21 M(-22.9%) |
| Mar 2018 | - | $17.12 M(+101.7%) |
| Dec 2017 | $8.49 M(+21.4%) | $8.49 M(-63.6%) |
| Sep 2017 | - | $23.31 M(+34.5%) |
| Jun 2017 | - | $17.33 M(+15.5%) |
| Mar 2017 | - | $14.99 M(+114.4%) |
| Dec 2016 | $6.99 M(+56.9%) | $6.99 M(-58.1%) |
| Sep 2016 | - | $16.68 M(+25.3%) |
| Jun 2016 | - | $13.31 M(+8.1%) |
| Mar 2016 | - | $12.31 M(+176.2%) |
| Dec 2015 | $4.46 M(+119.4%) | $4.46 M(-66.6%) |
| Sep 2015 | - | $13.33 M(+40.6%) |
| Jun 2015 | - | $9.49 M(+113.1%) |
| Mar 2015 | - | $4.45 M(+119.1%) |
| Dec 2014 | $2.03 M(-14.9%) | $2.03 M(-57.6%) |
| Sep 2014 | - | $4.79 M(-20.0%) |
| Jun 2014 | - | $5.99 M(-0.7%) |
| Mar 2014 | - | $6.03 M(+152.5%) |
| Dec 2013 | $2.39 M(+129.7%) | $2.39 M(-47.1%) |
| Sep 2013 | - | $4.51 M(+33.5%) |
| Jun 2013 | - | $3.38 M(+14.8%) |
| Mar 2013 | - | $2.95 M(+183.3%) |
| Dec 2012 | $1.04 M | $1.04 M(-66.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $3.13 M(-11.0%) |
| Jun 2012 | - | $3.52 M(+6.2%) |
| Mar 2012 | - | $3.32 M(+185.8%) |
| Dec 2011 | $1.16 M(+207.6%) | $1.16 M(-64.2%) |
| Jun 2011 | - | $3.24 M(+446.2%) |
| Sep 2009 | - | $593.70 K(+1355.1%) |
| Jun 2009 | - | $40.80 K(-89.2%) |
| Dec 2008 | $377.30 K(-79.1%) | $377.30 K(-74.5%) |
| Sep 2008 | - | $1.48 M(-21.4%) |
| Jun 2008 | - | $1.88 M(+37.9%) |
| Mar 2008 | - | $1.36 M(-24.5%) |
| Dec 2007 | $1.81 M(-10.1%) | $1.81 M(-4.6%) |
| Sep 2007 | - | $1.89 M(+14.8%) |
| Jun 2007 | - | $1.65 M(+11.8%) |
| Mar 2007 | - | $1.48 M(-26.6%) |
| Dec 2006 | $2.01 M(+7.8%) | $2.01 M(+39.1%) |
| Sep 2006 | - | $1.44 M(+1.0%) |
| Jun 2006 | - | $1.43 M(-9.5%) |
| Mar 2006 | - | $1.58 M(-15.3%) |
| Dec 2005 | $1.86 M(-13.5%) | $1.86 M(+43.2%) |
| Sep 2005 | - | $1.30 M(-31.1%) |
| Jun 2005 | - | $1.89 M(+13.1%) |
| Mar 2005 | - | $1.67 M(-22.4%) |
| Dec 2004 | $2.16 M(+160.4%) | $2.16 M(+471.0%) |
| Sep 2004 | - | $377.50 K(-43.0%) |
| Jun 2004 | - | $661.80 K(+19.3%) |
| Mar 2004 | - | $554.80 K(-33.0%) |
| Dec 2003 | $827.70 K(-43.4%) | $827.70 K(+1.6%) |
| Sep 2003 | - | $814.60 K(+45.4%) |
| Jun 2003 | - | $560.40 K(-17.9%) |
| Mar 2003 | - | $682.20 K(+8.7%) |
| Sep 2002 | - | $627.70 K(-8.3%) |
| Jun 2002 | - | $684.40 K(-40.7%) |
| Mar 2002 | - | $1.15 M(-13.2%) |
| Dec 2001 | $1.46 M(+5.0%) | - |
| Sep 2001 | - | $1.33 M(-6.5%) |
| Jun 2001 | - | $1.42 M(+2.1%) |
| Mar 2001 | - | $1.39 M(+5.5%) |
| Mar 2001 | $1.39 M(-21.9%) | - |
| Dec 2000 | - | $1.32 M(+3.4%) |
| Sep 2000 | - | $1.28 M(-21.8%) |
| Jun 2000 | - | $1.63 M(-8.4%) |
| Mar 2000 | $1.78 M(+27.4%) | $1.78 M(-0.9%) |
| Dec 1999 | - | $1.80 M(+5.9%) |
| Sep 1999 | - | $1.70 M(+41.7%) |
| Jun 1999 | - | $1.20 M(-14.3%) |
| Mar 1999 | $1.40 M | $1.40 M(+27.3%) |
| Dec 1998 | - | $1.10 M |
FAQ
- What is Inovio Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual accounts payable year-on-year change?
- What is Inovio Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly accounts payable year-on-year change?
What is Inovio Pharmaceuticals annual accounts payable?
The current annual accounts payable of INO is $4.65 M
What is the all time high annual accounts payable for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual accounts payable is $27.97 M
What is Inovio Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, INO annual accounts payable has changed by -$16.43 M (-77.95%)
What is Inovio Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of INO is $5.39 M
What is the all time high quarterly accounts payable for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly accounts payable is $39.57 M
What is Inovio Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, INO quarterly accounts payable has changed by +$737.20 K (+15.86%)